Metabolic syndrome, hormone levels, and inflammation in patients with erectile dysfunction

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Arrabal Polo, Miguel Ángel ^a   Arias Santiago, Salvador ^b   Pintado, Fernando López Carmona ^a   Merino Salas, Sergio ^a   Lahoz García, Clara ^a   Zuluaga Gómez, Armando ^a   Arrabal Martin, Miguel ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; D DIMER; ESTRADIOL; FIBRINOGEN; FOLLITROPIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; LUTEINIZING HORMONE; PROGESTERONE; PROLACTIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; ERYTHROCYTE SEDIMENTATION RATE; ESTRADIOL BLOOD LEVEL; FIBRINOGEN BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LIPOPROTEIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; SPAIN; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; BLOOD PRESSURE; BODY MASS; CASE CONTROL STUDY; EUNUCHOIDISM; MIDDLE AGED; NONPARAMETRIC TEST; PREVALENCE; RISK; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ERECTILE DYSFUNCTION; EUNUCHISM; HUMANS; INFLAMMATION; LINEAR MODELS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; SPAIN; STATISTICS, NONPARAMETRIC; TESTOSTERONE;

EID: 84867807963     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/272769     Document Type: Article

References (28)

1. Cohan P., Korenman S. G., Erectile dysfunction. The Journal of Clinical Endocrinology & Metabolism 2001 86 2192 2194
2. Rosen R. C., Riley A., Wagner G., Osterloh I. H., Kirkpatrick J., Mishra A., The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997 49 6 822 830 2-s2.0-0030926566 10.1016/S0090-4295(97)00238-0 (Pubitemid 27246947)
3. Navarrete R. V., Muoz J. G., Martín L. L., Cardoso J. V. G., Enguita C. G., Metabolic sindrome and erectile dysfunction. Archivos Espaoles de Urologia 2010 63 8 673 678 2-s2.0-78149251497
4. Guay A. T., ED: Erectile Dysfunction = Endothelial Dysfunction. Endocrinology and Metabolism Clinics of North America 2007 36 2 453 463 2-s2.0-34249337377 10.1016/j.ecl.2007.03.007 (Pubitemid 46817888)
5. Corona G., Mannucci E., Forti G., Maggi M., Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. International Journal of Andrology 2009 32 6 587 598 2-s2.0-70049083600 10.1111/j.1365-2605.2008.00951.x
6. Assmann G., Schulte H., Seedorf U., Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) study. International Journal of Obesity 2008 32 supplement 2 S11 S16 2-s2.0-43449101917 10.1038/ijo.2008.29 (Pubitemid 351671296)
7. Corona G., Monami M., Boddi V., Cameron-Smith M., Lotti F., de Vita G., Melani C., Balzi D., Sforza A., Forti G., Mannucci E., Maggi M., Male sexuality and cardiovascular risk. a cohort study in patients with erectile dysfunction. Journal of Sexual Medicine 2010 7 5 1918 1927 2-s2.0-77953580306 10.1111/j.1743-6109.2010.01744.x
8. Blake G. J., Ridker P. M., C-reactive protein and other inflammatory risk markers in acute coronary syndromes. Journal of the American College of Cardiology 2003 41 4, supplement S37 S42 10.1016/S0735-1097(02)02953-4 2-s2.0-0037454043
9. Vlachopoulos C., Aznaouridis K., Ioakeimidis N., Rokkas K., Vasiliadou C., Alexopoulos N., Stefanadi E., Askitis A., Stefanadis C., Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. European Heart Journal 2006 27 22 2640 2648 2-s2.0-33750913713 10.1093/eurheartj/ehl341 (Pubitemid 44729862)
10. Corona G., Maggi M., The role of testosterone in erectile dysfunction. Nature Reviews Urology 2010 7 1 46 56 2-s2.0-75949087002 10.1038/nrurol.2009.235
11. Corona G., Monami M., Rastrelli G., Aversa A., Tishova Y., Saad F., Lenzi A., Forti G., Mannucci E., Maggi M., Testosterone and metabolic syndrome: a meta-analysis study. Journal of Sexual Medicine 2011 8 1 272 283 2-s2.0-78650772878 10.1111/j.1743-6109.2010.01991.x
12. Maas R., Schwedhelm E., Albsmeier J., Böger R. H., The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vascular Medicine 2002 7 3 213 225 2-s2.0-0036961308 10.1191/1358863x02vm429ra (Pubitemid 36104323)
13. Müller A., Mulhall J. P., Cardiovascular disease, metabolic syndrome and erectile dysfunction. Current Opinion in Urology 2006 16 6 435 443 2-s2.0-33750303976 10.1097/01.mou.0000250284.83108.a6 (Pubitemid 44624578)
14. Heidler S., Temml C., Broessner C., Mock K., Rauchenwald M., Madersbacher S., Ponholzer A., Is the metabolic syndrome an independent risk factor for erectile dysfunction? Journal of Urology 2007 177 2 651 654 2-s2.0-33845986382 10.1016/j.juro.2006.09.043 (Pubitemid 46054028)
15. Bal K., Öder M., ahin A. S., Karata C. T., Demir Ö.., Can E., Gümü B. H., Özer K., ahin O. G., Esen A. A., Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. Urology 2007 69 2 356 360 2-s2.0-33847026126 10.1016/j.urology.2006.09.057 (Pubitemid 46274920)
16. Borges R., Temido P., Sousa L., Azinhais P., Conceião P., Pereira B., Leão R., Retroz E., Brandão Á., Cristo L., Sobral F., Metabolic syndrome and sexual (Dys)function. Journal of Sexual Medicine 2009 6 11 2958 2975 2-s2.0-70649107120 10.1111/j.1743-6109.2009.01412.x
17. Pohjantähti-Maaroos H., Palomäki A., Comparison of metabolic syndrome subjects with and without erectile dysfunctionlevels of circulating oxidised LDL and arterial elasticity. International Journal of Clinical Practice 2011 65 3 274 280 2-s2.0-79951644345 10.1111/j.1742-1241.2010.02595.x
18. Eaton C. B., Liu Y. L., Mittleman M. A., Miner M., Glasser D. B., Rimm E. B., A retrospective study of the relationship between biomarkers of atherosclerosis and erectile dysfunction in 988 men. International Journal of Impotence Research 2007 19 2 218 225 2-s2.0-33847399655 10.1038/sj.ijir.3901519 (Pubitemid 46340843)
19. Corona G., Mannucci E., Fisher A. D., Lotti F., Petrone L., Balercia G., Bandini E., Forti G., Maggi M., Low levels of androgens in men with erectile dysfunction and obesity. Journal of Sexual Medicine 2008 5 10 2454 2463 2-s2.0-53549128068 10.1111/j.1743-6109.2008.00856.x
20. Shabsigh R., Arver S., Channer K. S., Eardley I., Fabbri A., Gooren L., Heufelder A., Jones H., Meryn S., Zitzmann M., The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. International Journal of Clinical Practice 2008 62 5 791 798 2-s2.0-42149123373 10.1111/j.1742-1241.2008. 01696.x (Pubitemid 351533668)
21. Corona G., Rastrelli G., Morelli A., Vignozzi L., Mannucci E., Maggi M., Hypogonadism and metabolic syndrome. Journal of Endocrinological Investigation 2011 34 7 557 567 2-s2.0-80054089894 10.3275/7806
22. Arias-Santiago S., Gutiérrez-Salmerón M. T., Castellote-Caballero L., Buendía-Eisman A., Naranjo-Sintes R., Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. Journal of the American Academy of Dermatology 2010 63 3 420 429 2-s2.0-77955923963 10.1016/j.jaad.2009.10.018
23. Arias-Santiago S., Gutiérrez-Salmerón M. T., Buendía-Eisman A., Girón-Prieto M. S., Naranjo-Sintes R., Hypertension and aldosterone levels in women with early-onset androgenetic alopecia. British Journal of Dermatology 2010 162 4 786 789 2-s2.0-77949861689 10.1111/j.1365-2133.2009.09588.x
24. Arias-Santiago S., Gutiérrez-Salmerón M. T., Castellote-Caballero L., Naranjo-Sintes R., Elevated aldosterone levels in patients with androgenetic alopecia. British Journal of Dermatology 2009 161 5 1196 1198 2-s2.0-71949103086 10.1111/j.1365-2133.2009.09293.x
25. Arias-Santiago S., Gutiérrez-Salmerón M. T., Buendía-Eisman A., Girón-Prieto M. S., Naranjo-Sintes R., Sex hormone-binding globulin and risk of hyperglycemia in patients with androgenetic alopecia. Journal of the American Academy of Dermatology 2011 2-s2.0-79955120407 10.1016/j.jaad.2010.05.002
26. Somani B., Khan S., Donat R., Screening for metabolic syndrome and testosterone deficiency in patients with erectile dysfunction: results from the first UK prospective study. BJU International 2010 106 5 688 690 2-s2.0-77955897292 10.1111/j.1464-410X.2009.09145.x
27. Traish A. M., Feeley R. J., Guay A., Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction. FEBS Journal 2009 276 20 5755 5767 2-s2.0-70349510639 10.1111/j.1742-4658.2009.07305.x
28. Rajmil O., Fernández M., Blasco A., Arrús J. A., Montaes R., Rodríguez-Espinosa J., Association of nocturnal penile rigidity with testosterone, metabolic syndrome, and other variables: a prospective cross-sectional pilot study. Actas Urologicas Espaolas 2011 35 459 467